Zoeken | Soocian

Pratiksha Chokhande toegevoegd een audio Health
2026-06-16 06:53:27 -

Dextromethorphan Market Assessment and Competitive Analysis Report
"Dextromethorphan Market Summary According to the latest report published by Data Bridge Market Research, the Dextromethorphan Market Data Bridge Market Research analyses that the global dextromethorphan market which was USD 487.25 million in 2022, is expected to reach USD 587.31 million by 2030, and is expected to undergo a CAGR of 4.8% during the forecast period of 2023 to...

1

0 Reacties 1 aandelen 386 Views 0 voorbeeld

Please log in to like, share and comment!
Pratiksha Chokhande toegevoegd een audio Health
2026-06-04 05:04:32 -

Dextromethorphan Market Growth Opportunities and Industry Trends Analysis
"Dextromethorphan Market Summary According to the latest report published by Data Bridge Market Research, the Dextromethorphan Market Data Bridge Market Research analyses that the global dextromethorphan market which was USD 487.25 million in 2022, is expected to reach USD 587.31 million by 2030, and is expected to undergo a CAGR of 4.8% during the forecast period of 2023 to 2030....

0 Reacties 0 aandelen 207 Views 0 voorbeeld

Please log in to like, share and comment!
Pratiksha Chokhande toegevoegd een audio Health
2026-07-30 10:07:44 -

Dextromethorphan Market Report: Size, Share, Trends & Forecast to 2033
"Dextromethorphan Market Summary According to the latest report published by Data Bridge Market Research, the Dextromethorphan Market Data Bridge Market Research analyses that the global dextromethorphan market which was USD 487.25 million in 2022, is expected to reach USD 587.31 million by 2030, and is expected to undergo a CAGR of 4.8% during the forecast period of 2023 to 2030. An...

0 Reacties 0 aandelen 263 Views 0 voorbeeld

Please log in to like, share and comment!
Surbhi Verma toegevoegd een audio Health
2026-07-24 11:05:22 -

Pseudobulbar Treatment Market: How Is Dextromethorphan-Quinidine Fixed-Dose Therapy Becoming the Fastest-Growing Pharmacological Standard?
Dextromethorphan-quinidine fixed-dose combination (Nuedexta, Avanir/Otsuka) — the first FDA-approved therapy specifically indicated for pseudobulbar affect (PBA) in amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) patients, modulating glutamatergic and sigma-1 receptor signaling while inhibiting CYP2D6 metabolism — creates the most commercially dynamic market segment,...

0 Reacties 0 aandelen 352 Views 0 voorbeeld

Please log in to like, share and comment!